deferoxamine has been researched along with concanavalin a in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fragonas, JC; Hunt, NH | 1 |
| Golub, SH; Ramsdell, FJ; Shau, H | 1 |
| Badenoch-Jones, P; Bowern, N; Doherty, PC; Ramshaw, IA | 1 |
| Chinea, M; Romano, EL; Soyano, A | 1 |
| Hourahane, D; Jones, BM; Worwood, M | 1 |
| Baliga, BS; Kitchens, D; Kuvibidila, SR | 1 |
| Hashimoto, K; Hisakawa, N; Nishiya, K; Tahara, K; Wang, H | 1 |
| Awad, AS; Darwish, SF; El-Bakly, WM; El-Demerdash, E; El-Naga, RN | 1 |
8 other study(ies) available for deferoxamine and concanavalin a
| Article | Year |
|---|---|
Effects of anti-oxidants on ornithine decarboxylase in mitogenically-activated T lymphocytes.
Topics: Animals; Antioxidants; Cells, Cultured; Concanavalin A; Deferoxamine; Ferricyanides; Ionomycin; Lymph Nodes; Lymphocyte Activation; Masoprocol; Mice; Mice, Inbred BALB C; Ornithine Decarboxylase; RNA, Messenger; T-Lymphocytes; Tetradecanoylphorbol Acetate | 1992 |
Role of proliferation in LAK cell development.
Topics: Cell Separation; Concanavalin A; Cytotoxicity, Immunologic; Deferoxamine; Growth Inhibitors; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Interleukin-2; Killer Cells, Natural; Lymphocyte Activation; Mitomycin; Mitomycins; Phytohemagglutinins; Recombinant Proteins | 1988 |
Effect of an iron-chelating agent on lymphocyte proliferation.
Topics: Animals; Cell Division; Concanavalin A; Deferoxamine; Humans; In Vitro Techniques; Iron; Lipopolysaccharides; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Metals; Mice; T-Lymphocytes; Time Factors | 1984 |
The effect of desferrioxamine on the proliferative response of rat lymphocytes stimulated with various mitogens in vitro.
Topics: Animals; Cell Division; Concanavalin A; Deferoxamine; Drug Interactions; In Vitro Techniques; Lymphocytes; Male; Mitogens; Rats; Rats, Inbred Strains; Spleen; Thymidine; Time Factors | 1984 |
Accumulation and release of isoferritins during incubation in vitro of human peripheral blood mononuclear cells.
Topics: Cells, Cultured; Concanavalin A; Deferoxamine; Ferric Compounds; Ferritins; Humans; L-Lactate Dehydrogenase; Leukocytes; Lymphocytes; Monocytes; Nitrilotriacetic Acid; Phagocytosis; Time Factors | 1984 |
In vivo and in vitro iron deficiency reduces protein kinase C activity and translocation in murine splenic and purified T cells.
Topics: Anemia, Iron-Deficiency; Animals; Body Weight; CD3 Complex; Cell Division; Cell Membrane; Cells, Cultured; Chelating Agents; Concanavalin A; Culture Media, Serum-Free; Cytosol; Deferoxamine; Female; Hemoglobins; Iron; Iron, Dietary; Liver; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mitogens; Phytohemagglutinins; Protein Kinase C; Spleen; T-Lymphocytes; Time Factors | 1999 |
Suppressive effect of iron on concanavalin A-induced multinucleated giant cell formation by human monocytes.
Topics: Acid Phosphatase; Antigens, CD; Cell Fusion; Cells, Cultured; Citrates; Concanavalin A; Deferoxamine; Dose-Response Relationship, Drug; Ferric Compounds; Giant Cells; Humans; Intercellular Adhesion Molecule-1; Iron; Isoenzymes; Monocytes; NG-Nitroarginine Methyl Ester; Sodium Citrate; Tartrate-Resistant Acid Phosphatase; Time Factors | 2003 |
Antifibrotic mechanism of deferoxamine in concanavalin A induced-liver fibrosis: Impact on interferon therapy.
Topics: Animals; Antiviral Agents; Concanavalin A; Deferoxamine; Interferon alpha-2; Interferon-alpha; Iron; Liver; Liver Cirrhosis; Mitogens; Oxidative Stress; Polyethylene Glycols; Rats; Rats, Wistar; Recombinant Proteins; Siderophores | 2015 |